PropertyValue
?:abstract
  • The present year saw the emergence of a pandemic Corona Virus Disease of 2019 (COVID 19) The unpreparedness for the pandemic and lack of drugs/vaccine against this virus has led to a high mortality rate across the world In the process, a number of drugs have been tried against the corona virus including antivirals like remdesivir, lopinavir-ritonavir, and favipiravir, monoclonal antibodies like tocilizumab and sarilumab and antimalarial drugs like chloroquine and hydroxychloroquine At the present time, none of these drugs have reported efficacy against the virus Here we present a review of all these drugs, their proposed mechanism of action against the corona virus and their status in clinical trials © 2020 The Author(s) This is an open access article and applies the Creative Commons Attribution License (http://creativecommons org/licenses/by-nc/4 0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited
is ?:annotates of
?:creator
?:journal
  • Pharmaceutical_Sciences
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Investigational drugs for the COVID 19 pandemic - A concise review
?:type
?:who_covidence_id
  • #971687
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/gortolye>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/gortolye>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all